Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 517

1.

Impact of Menopausal Hormone Formulations on Pituitary-Ovarian Regulatory Feedback.

Kling JM, Dowling NM, Bimonte-Nelson HA, Gleason CE, Kantarci K, Manson JE, Taylor HS, Brinton EA, Lobo RA, Cedars ML, Pal L, Neal-Perry G, Naftolin F, Harman SM, Miller VM.

Am J Physiol Regul Integr Comp Physiol. 2019 Oct 30. doi: 10.1152/ajpregu.00234.2019. [Epub ahead of print]

PMID:
31663769
2.

Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.

Naftolin F, Friedenthal J, Nachtigall R, Nachtigall L.

F1000Res. 2019 Sep 3;8. pii: F1000 Faculty Rev-1576. doi: 10.12688/f1000research.15548.1. eCollection 2019. Review.

3.

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Miller VM, Naftolin F, Asthana S, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Gleason CE, Hodis HN, Jayachandran M, Kantarci K, Lobo RA, Manson JE, Pal L, Santoro NF, Taylor HS, Harman SM.

Menopause. 2019 Sep;26(9):1071-1084. doi: 10.1097/GME.0000000000001326.

4.

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Miller VM, Naftolin F, Asthana S, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Gleason CE, Hodis HN, Jayachandran M, Kantarci K, Lobo RA, Manson JE, Pal L, Santoro NF, Taylor HS, Harman SM.

Menopause. 2019 Apr 1. doi: 10.1097/GME.0000000000001326. [Epub ahead of print]

PMID:
30939537
5.

Aromatase and estrogen receptor immunoreactivity in the coronary arteries of monkeys and human subjects.

Diano S, Horvath TL, Mor G, Register T, Adams M, Harada N, Naftolin F.

Menopause. 2018 Nov;25(11):1201-1207. doi: 10.1097/GME.0000000000001219.

PMID:
30358714
6.

Contemporary Hormonal Contraception and the Risk of Breast Cancer.

Nachtigall L, Naftolin F, Keefe DL.

N Engl J Med. 2018 Mar 29;378(13):1265. doi: 10.1056/NEJMc1800054. No abstract available.

PMID:
29595938
7.

Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).

Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Du W, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Neal-Perry G, Santoro NF, Harman SM.

JAMA Intern Med. 2017 Oct 1;177(10):1471-1479. doi: 10.1001/jamainternmed.2017.3877.

8.

Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).

Cintron D, Lahr BD, Bailey KR, Santoro N, Lloyd R, Manson JE, Neal-Perry G, Pal L, Taylor HS, Wharton W, Naftolin F, Harman SM, Miller VM.

Menopause. 2018 Feb;25(2):145-153. doi: 10.1097/GME.0000000000000971.

9.

A multicentre evaluation of an opioid patient-provider agreement.

Pergolizzi JV, Curro FA, Col N, Ghods MP, Vena D, Taylor R, Naftolin F, LeQuang JA.

Postgrad Med J. 2017 Oct;93(1104):613-617. doi: 10.1136/postgradmedj-2016-134607. Epub 2017 May 10.

PMID:
28490546
10.

Bisphenol A influences oestrogen- and thyroid hormone-regulated thyroid hormone receptor expression in rat cerebellar cell culture.

Somogyi V, Horváth TL, Tóth I, Bartha T, Frenyó LV, Kiss DS, Jócsák G, Kerti A, Naftolin F, Zsarnovszky A.

Acta Vet Hung. 2016 Dec;64(4):497-513.

PMID:
27993100
11.

Opioid, NSAID, and OTC Analgesic Medications for Dental Procedures: PEARL Network Findings.

Wong YJ, Keenan J, Hudson K, Bryan H, Naftolin F, Thompson VP, Craig RG, Vena D, Collie D, Wu H, Matthews AG, Grill AC, Curro FA.

Compend Contin Educ Dent. 2016 Nov/Dec;37(10):710-718.

PMID:
27875056
12.

The Ovarian Renin-Angiotensin System (OVRAS): A Major Factor in Ovarian Function and Disease.

Palumbo A, Ávila J, Naftolin F.

Reprod Sci. 2016 Dec;23(12):1644-1655. Review.

PMID:
27821561
13.

Sex Steroids Block the Initiation of Atherosclerosis.

Naftolin F, Mehr H, Fadiel A.

Reprod Sci. 2016 Dec;23(12):1620-1625. Review.

14.

Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.

Santoro N, Allshouse A, Neal-Perry G, Pal L, Lobo RA, Naftolin F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Dunn M, Gleason CE, Hodis HN, Isaac B, Magnani M, Manson JE, Miller VM, Taylor HS, Wharton W, Wolff E, Zepeda V, Harman SM.

Menopause. 2017 Mar;24(3):238-246. doi: 10.1097/GME.0000000000000756.

15.

Expression of Ezrin and Estrogen Receptors During Cervical Carcinogenesis.

Fadiel A, Choi SD, Park B, Kim TH, Buldo-Licciardi J, Ahmadi M, Arslan A, Mittal K, Naftolin F.

Reprod Sci. 2017 May;24(5):706-712. doi: 10.1177/1933719116667222. Epub 2016 Sep 29.

PMID:
27688241
16.

Aromatase: Contributions to Physiology and Disease in Women and Men.

Blakemore J, Naftolin F.

Physiology (Bethesda). 2016 Jul;31(4):258-69. doi: 10.1152/physiol.00054.2015. Review.

17.

Human Milk Bacterial and Glycosylation Patterns Differ by Delivery Mode.

Hoashi M, Meche L, Mahal LK, Bakacs E, Nardella D, Naftolin F, Bar-Yam N, Dominguez-Bello MG.

Reprod Sci. 2016 Jul;23(7):902-7. doi: 10.1177/1933719115623645. Epub 2015 Dec 27.

PMID:
26711314
18.

Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study.

Miller VM, Jenkins GD, Biernacka JM, Heit JA, Huggins GS, Hodis HN, Budoff MJ, Lobo RA, Taylor HS, Manson JE, Black DM, Naftolin F, Harman SM, de Andrade M.

Physiol Genomics. 2016 Jan;48(1):33-41. doi: 10.1152/physiolgenomics.00029.2015. Epub 2015 Oct 27.

19.

Hormone therapy and ovarian cancer.

Naftolin F, Friedenthal J, Blakemore J, Nachtigall L.

Lancet. 2015 Sep 12;386(9998):1037. doi: 10.1016/S0140-6736(15)00137-3. No abstract available.

PMID:
26382990
20.

Case Presentations Demonstrating Periodontal Treatment Variation: PEARL Network.

Curro FA, Grill AC, Matthews AG, Martin J, Kalenderian E, Craig RG, Naftolin F, Thompson VP.

Compend Contin Educ Dent. 2015 Jun;36(6):432-40.

PMID:
26053783
21.

Defining Periodontitis for "Person-Centered Care".

Curro FA, Martin J, Naftolin F, Grill AC, Thompson VP.

Compend Contin Educ Dent. 2015 Jun;36(6):430-1. No abstract available.

PMID:
26053782
22.

Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.

Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S.

PLoS Med. 2015 Jun 2;12(6):e1001833; discussion e1001833. doi: 10.1371/journal.pmed.1001833. eCollection 2015 Jun.

23.

Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network.

Curro FA, Robbins DA, Naftolin F, Grill AC, Vena D, Terracio L.

Clin Investig (Lond). 2015;5(2):145-159.

24.

Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.

Fadiel A, Song J, Tivon D, Hamza A, Cardozo T, Naftolin F.

Reprod Sci. 2015 Feb;22(2):146-55. doi: 10.1177/1933719114549853. Epub 2014 Sep 25.

PMID:
25258361
25.

ISGE statement on oral emergency contraception.

Glasier A, Gemzell-Danielsson K, Bouchard P, Genazzani AR, Al-Azzawi F, Berga S, Birkhaeuser M, Brincat M, De Melo NR, Foidart JM, Kenemans P, Lunenfeld B, Maruo T, Milewicz A, Naftolin F, Ng EH, Schindler A, Simon C, Simoncini T, Simpson E, Siseles N, Smetnik V, Tarlatzis B, von Schoultz B.

Gynecol Endocrinol. 2014 Oct;30(10):681-2. doi: 10.3109/09513590.2014.950649. Review.

PMID:
25242337
26.

Abnormal fingernail beds following carbon monoxide poisoning: a case report and review of the literature.

Hatami M, Naftolin F, Khatamee MA.

J Med Case Rep. 2014 Jul 29;8:263. doi: 10.1186/1752-1947-8-263. Review.

27.

Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.

Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, Hopkins PN, Lobo RA, Manson JE, Merriam GR, Miller VM, Neal-Perry G, Santoro N, Taylor HS, Vittinghoff E, Yan M, Hodis HN.

Ann Intern Med. 2014 Aug 19;161(4):249-60. doi: 10.7326/M14-0353.

PMID:
25069991
28.

The separation of sexual activity and reproduction in human social evolution.

Morin S, Keefe D, Naftolin F.

Adv Exp Med Biol. 2014;814:159-67. doi: 10.1007/978-1-4939-1031-1_14. Review.

PMID:
25015809
29.

Hypothalamic sidedness in mitochondrial metabolism: new perspectives.

Toth I, Kiss DS, Goszleth G, Bartha T, Frenyo LV, Naftolin F, Horvath TL, Zsarnovszky A.

Reprod Sci. 2014 Dec;21(12):1492-8. doi: 10.1177/1933719114530188. Epub 2014 Apr 16.

PMID:
24740989
30.

The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition.

Wharton W, Gleason CE, Dowling NM, Carlsson CM, Brinton EA, Santoro MN, Neal-Perry G, Taylor H, Naftolin F, Lobo RA, Merriam G, Manson JE, Cedars MI, Miller VM, Black DM, Budoff M, Hodis HN, Harman SM, Asthana S.

J Alzheimers Dis. 2014;40(2):331-41. doi: 10.3233/JAD-130245.

31.

The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.

Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. Review.

PMID:
24172877
32.

Brain health and cognitive and mood disorders in ageing women.

Silva I, Naftolin F.

Best Pract Res Clin Obstet Gynaecol. 2013 Oct;27(5):661-72. doi: 10.1016/j.bpobgyn.2013.06.005. Epub 2013 Sep 3. Review.

PMID:
24007951
33.

Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.

Dowling NM, Gleason CE, Manson JE, Hodis HN, Miller VM, Brinton EA, Neal-Perry G, Santoro MN, Cedars M, Lobo R, Merriam GR, Wharton W, Naftolin F, Taylor H, Harman SM, Asthana S.

PLoS One. 2013 Jul 17;8(7):e68741. doi: 10.1371/journal.pone.0068741. Print 2013.

34.

Person-centric clinical trials: an opportunity for the good clinical practice (GCP)-practice-based research network.

Curro FA, Robbins DA, Millenson ML, Fox CH, Naftolin F.

J Clin Pharmacol. 2013 Oct;53(10):1091-4. doi: 10.1002/jcph.138. Epub 2013 Jul 19.

PMID:
23868608
35.

Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study.

Ogorodnikova AD, Khan UI, McGinn AP, Zeb I, Budoff MJ, Harman SM, Miller VM, Brinton EA, Manson JE, Hodis HN, Merriam GR, Cedars MI, Taylor HS, Naftolin F, Lobo RA, Santoro N, Wildman RP.

Obesity (Silver Spring). 2013 Aug;21(8):1726-33. doi: 10.1002/oby.20200. Epub 2013 May 13.

36.

Bioinformatic analysis of benzo-α-pyrene-induced damage to the human placental insulin-like growth factor-1 gene.

Fadiel A, Epperson B, Shaw MI, Hamza A, Petito J, Naftolin F.

Reprod Sci. 2013 Aug;20(8):917-28. doi: 10.1177/1933719112468946. Epub 2013 Jan 23.

37.

Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS).

Wolff EF, He Y, Black DM, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Pal L, Santoro N, Zhang H, Harman SM, Taylor HS.

Fertil Steril. 2013 Apr;99(5):1385-91. doi: 10.1016/j.fertnstert.2012.11.053. Epub 2013 Jan 8.

38.

Practice-Based Research Network Infrastructure Design for Institutional Review Board Risk Assessment and Generalizability of Clinical Results.

Curro F, Thompson VP, Naftolin F, Grill A, Vena D, Terracio L, Hashimoto M, Buchholz M, McKinstry A, Cannon D, Alfano V, Gooden T, Vernillo A, Czeisler E.

Ther Innov Regul Sci. 2013 Jan;47(1):82-89.

39.

The pros and cons of plant estrogens for menopause.

Bedell S, Nachtigall M, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jan;139:225-36. doi: 10.1016/j.jsbmb.2012.12.004. Epub 2012 Dec 25. Review.

PMID:
23270754
40.

Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study.

Miller VM, Petterson TM, Jeavons EN, Lnu AS, Rider DN, Heit JA, Cunningham JM, Huggins GS, Hodis HN, Budoff MJ, Santoro N, Hopkins PN, Lobo RA, Manson JE, Naftolin F, Taylor HS, Harman SM, de Andrade M.

Physiol Genomics. 2013 Jan 15;45(2):79-88. doi: 10.1152/physiolgenomics.00114.2012. Epub 2012 Nov 27.

41.

The PBRN initiative: transforming new technologies to improve patient care.

Curro FA, Vena D, Naftolin F, Terracio L, Thompson VP.

J Dent Res. 2012 Jul;91(7 Suppl):12S-20S.

42.

Protein flexibility and conformational states of Leishmania antigen eIF-4A: identification of a novel plausible protein adjuvant using comparative genomics and molecular modeling.

Wei NN, Hamza A, Hao C, Johnson-Scalise T, Xiu Z, Naftolin F, Zhan CG.

J Biomol Struct Dyn. 2013;31(8):841-53. doi: 10.1080/07391102.2012.713781. Epub 2012 Sep 10.

PMID:
22963753
43.

Practice based research networks impacting periodontal care: PEARL Initiative.

Curro FA, Thompson VP, Grill A, Vena D, Terracio L, Naftolin F.

J Periodontol. 2013 May;84(5):567-71. doi: 10.1902/jop.2012.120116. Epub 2012 Jun 15.

44.

Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study.

Huang G, Wang D, Khan UI, Zeb I, Manson JE, Miller V, Hodis HN, Budoff MJ, Merriam GR, Harman MS, Brinton EA, Cedars MI, Su Y, Lobo RA, Naftolin F, Santoro N, Taylor HS, Wildman RP.

Cardiovasc Diabetol. 2012 May 15;11:52. doi: 10.1186/1475-2840-11-52.

45.

Ezrin overexpression by transformed human ovarian surface epithelial cells, ovarian cleft cells, and serous ovarian adenocarcinoma cells.

Fadiel A, Chen Z, Ulukus E, Ohtani K, Hatami M, Naftolin F.

Reprod Sci. 2012 Aug;19(8):797-805. doi: 10.1177/1933719111433884. Epub 2012 Apr 3.

PMID:
22477337
46.

How we almost discovered LH receptors, but didn't.

Lunenfeld B, Naftolin F.

Gynecol Endocrinol. 2012 Mar;28 Suppl 1:5-8. doi: 10.3109/09513590.2012.651977. Review.

PMID:
22394298
47.

Neuroendocrine control of ovulation.

Berga S, Naftolin F.

Gynecol Endocrinol. 2012 Mar;28 Suppl 1:9-13. doi: 10.3109/09513590.2012.651929. Review.

PMID:
22283375
48.

The International Society of Gynecological Endocrinology and its president.

Naftolin F, Petraglia F, Simoncini T.

Gynecol Endocrinol. 2012 Mar;28 Suppl 1:1. doi: 10.3109/09513590.2012.652417. No abstract available.

PMID:
22273470
49.
50.

Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS).

Huang G, Wang D, Zeb I, Budoff MJ, Harman SM, Miller V, Brinton EA, El Khoudary SR, Manson JE, Sowers MR, Hodis HN, Merriam GR, Cedars MI, Taylor HS, Naftolin F, Lobo RA, Santoro N, Wildman RP.

Atherosclerosis. 2012 Mar;221(1):198-205. doi: 10.1016/j.atherosclerosis.2011.12.004. Epub 2011 Dec 9.

Supplemental Content

Loading ...
Support Center